08/13/2025
6:29 PM | ArriVent BioPharma (Subject)
SUVRETTA CAPITAL MANAGEMENT, LLC (Filed by)
| Form SCHEDULE 13G/A | |
08/13/2025
6:43 PM | ArriVent BioPharma (Subject)
ORBIMED ADVISORS LLC (Filed by)
| Form SCHEDULE 13D/A | |
08/13/2025
5:00 PM | ArriVent BioPharma (Subject)
INFINITUM ASSET MANAGEMENT, LLC (Filed by)
| Form SCHEDULE 13G | |
08/11/2025
7:00 AM | ArriVent BioPharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/11/2025
7:01 AM | ArriVent BioPharma (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/21/2025
7:08 AM | ArriVent BioPharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/15/2025
6:00 AM | ArriVent BioPharma (Issuer)
LaChapelle Robin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/23/2025
6:06 AM | ArriVent BioPharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/20/2025
6:29 PM | ArriVent BioPharma (Issuer)
Nolet Chris (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2025
6:31 PM | ArriVent BioPharma (Issuer)
Hohneker John (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2025
6:32 PM | ArriVent BioPharma (Issuer)
Peterson Kristine (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for AVBP and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for ArriVent BioPharma and its competitors with MarketBeat's FREE daily newsletter. |
06/20/2025
6:33 PM | ArriVent BioPharma (Issuer)
Parsey Merdad (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/12/2025
8:35 AM | ArriVent BioPharma (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/12/2025
7:00 AM | ArriVent BioPharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/28/2025
3:30 PM | ArriVent BioPharma (Filer)
| Form ARS | |
04/28/2025
7:15 AM | ArriVent BioPharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/03/2025
6:21 AM | ArriVent BioPharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/03/2025
6:29 AM | ArriVent BioPharma (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
03/03/2025
6:18 AM | ArriVent BioPharma (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/14/2025
8:00 PM | ArriVent BioPharma (Subject)
Novo Holdings A/S (Filed by)
| Form SCHEDULE 13G | |
02/03/2025
6:05 AM | ArriVent BioPharma (Filer)
| Form S-3ASR | |
01/21/2025
6:21 PM | ArriVent BioPharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/14/2024
3:33 PM | ArriVent BioPharma (Subject)
HHLR ADVISORS, LTD. (Filed by)
| Form SC 13G | |
11/14/2024
7:00 AM | ArriVent BioPharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/14/2024
7:01 AM | ArriVent BioPharma (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/12/2024
1:45 PM | ArriVent BioPharma (Subject)
Sofinnova Venture Partners XI, L.P. (Filed by)
| Form SC 13G | |
10/24/2024
1:02 PM | ArriVent BioPharma (Subject)
BlackRock, Inc. (Filed by)
| Form SC 13G | |
09/23/2024
5:14 PM | ArriVent BioPharma (Issuer)
LaChapelle Robin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/09/2024
11:15 AM | ArriVent BioPharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
MarketBeat All Access